Context Therapeutics Inc (CNTX) — Cash Flow-to-Debt Ratio
Context Therapeutics Inc (CNTX) has a Cash Flow-to-Debt Ratio of -0.88x as of June 2026, meaning its operating cash flow of $-7.02 Million could theoretically repay -1% of its total liabilities ($7.96 Million) in one year. See Context Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Context Therapeutics Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Context Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see CNTX cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Context Therapeutics Inc (2016–2025)
Year-by-year debt coverage analysis for Context Therapeutics Inc. Check Context Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.29x | $-26.39 Million | $8.02 Million | ▲ +35.3% |
| 2024 | -5.09x | $-14.56 Million | $2.86 Million | ▼ -1.3% |
| 2023 | -5.02x | $-21.05 Million | $4.19 Million | ▼ -18.9% |
| 2022 | -4.22x | $-13.55 Million | $3.21 Million | ▼ -45.6% |
| 2021 | -2.90x | $-8.80 Million | $3.03 Million | ▼ -4775.3% |
| 2020 | -0.06x | $-1.03 Million | $17.39 Million | ▲ +49.2% |
| 2019 | -0.12x | $-2.84 Million | $24.23 Million | ▲ +95.1% |
| 2017 | -2.38x | $-22.35 Million | $9.38 Million | ▲ +15.2% |
| 2016 | -2.81x | $-30.57 Million | $10.89 Million | — |